Trial Profile
An Open Labeled, Non comparative, Phase I Study to Evaluate the Safety and tolerability of a Fully Liquid Pentavalent DTwP-HepB-Hib Vaccine (My FiveTM, Panacea Biotec Ltd.) in Healthy Subjects 15-18 months of age.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Hib-DTP-hepatitis B vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors Panacea Biotec
- 04 Oct 2011 New trial record